This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient.
Market Segmentation Analysis
- Review of the ER, OR and ICU market segments, including their dynamics, trends,
structure, size, growth and major suppliers.
- Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology,
hematology and coagulation procedures by market segment:
- Emergency Rooms
- Operating/Recovery Suites
and test category:
- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Flow Cytometry
- Drugs of Abuse
- Endocrine Function
- Tumor Markers
Sales and Market Share Analysis
- Sales and market shares of major reagent and instrument suppliers.
Current and Emerging Products
- Analysis of over 130 diagnostic procedures.
- Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers,
both currently marketed and those in development, including their operating characteristics,
features and selling prices.
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing POC diagnostic technologies
and products, by test.
- Assessments of major suppliers and emerging market entrants, including their sales,
product portfolios, marketing tactics, joint ventures, and new products in R&D.
- Specific opportunities for new POC instruments and reagent systems with potentially
significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.
Contains 973 pages and 153 tables
SIMILAR MARKET STUDIES
2016 Malta Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing-Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.Highlights- Five-year test volume and sales forecasts- Feature comparison of major analyzers- Profiles of market players and start-up firms developing innovative ...
October 2016 | $0 | View Details >>
2017 Cyprus Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales ...
March 2017 | $0 | View Details >>
This new report from VPGMarketResearch.com provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:
November 1999 | $0 | View Details >>
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the Italian market; provides estimates of the specimen, test and ...
September 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research